Pubfacts - Scientific Publication Data
  • Categories
  • Journals
  • ->
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.

Authors:
Richard A Goodman Kimberly A Lochner Madhav Thambisetty Thomas S Wingo Samuel F Posner Shari M Ling

Alzheimers Dement 2017 01 10;13(1):28-37. Epub 2016 May 10.

Centers for Medicare & Medicaid Services, Baltimore, MD, USA.

Introduction: Rapid growth of the older adult population requires greater epidemiologic characterization of dementia. We developed national prevalence estimates of diagnosed dementia and subtypes in the highest risk United States (US) population.

Methods: We analyzed Centers for Medicare & Medicaid administrative enrollment and claims data for 100% of Medicare fee-for-service beneficiaries enrolled during 2011-2013 and age ≥68 years as of December 31, 2013 (n = 21.6 million).

Results: Over 3.1 million (14.4%) beneficiaries had a claim for a service and/or treatment for any dementia subtype. Dementia not otherwise specified was the most common diagnosis (present in 92.9%). The most common subtype was Alzheimer's (43.5%), followed by vascular (14.5%), Lewy body (5.4%), frontotemporal (1.0%), and alcohol induced (0.7%). The prevalence of other types of diagnosed dementia was 0.2%.

Discussion: This study is the first to document concurrent prevalence of primary dementia subtypes among this US population. The findings can assist in prioritizing dementia research, clinical services, and caregiving resources.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2016.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104686PMC
January 2017

Publication Analysis

Top Keywords

dementia subtypes
12
fee-for-service beneficiaries
8
united states
8
medicare fee-for-service
8
diagnosed dementia
8
dementia
7
treatment dementia
4
dementia subtype
4
service and/or
4
claim service
4
and/or treatment
4
dementia common
4
common subtype
4
subtype alzheimer's
4
929% common
4
diagnosis 929%
4
beneficiaries claim
4
common diagnosis
4
subtype dementia
4
n = 216 millionresults
4

Altmetric Statistics


Show full details
7 Total Shares
1 News Outlets
6 Tweets
7 Citations

Similar Publications

Expanding the clinical spectrum of adult-onset neuronal intranuclear inclusion disease.

Authors:
Yuwen Cao Jingying Wu Yunhua Yue Chao Zhang Shihua Liu Ping Zhong Shige Wang Xiaojun Huang Weiping Deng Jing Pan Lan Zheng Qing Liu Liang Shang Benyan Zhang Jie Yang Guang Chen Shufen Chen Li Cao Xinghua Luan

Acta Neurol Belg 2021 Feb 24. Epub 2021 Feb 24.

Department of Neurology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Neuronal intranuclear inclusion disease (NIID) is a heterogeneous neurodegenerative disease with multiple clinical subtypes. Recent breakthroughs on neuroimaging, skin biopsy and genetic testing have facilitated the diagnosis. We aim to investigate the clinical characteristics of Chinese NIID patients to further refine the spectrum. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Cerebral amyloid angiopathy-related inflammation: current status and future implications.

Authors:
Juan-Juan Wu Ming Yao Jun Ni

Chin Med J (Engl) 2021 Feb 23. Epub 2021 Feb 23.

Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.

Abstract: Cerebral amyloid angiopathy-related inflammation (CAA-RI) is a rare but increasingly recognized subtype of CAA. CAA-RI consists of two subtypes: inflammatory cerebral amyloid angiopathy and amyloid β (Aβ)-related angiitis. Acute or subacute onset of cognitive decline or behavioral changes is the most common symptom of CAA-RI. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Aging Brain Mechanics: Progress and Promise of Magnetic Resonance Elastography.

Authors:
Lucy V Hiscox Hillary Schwarb Matthew D J McGarry Curtis L Johnson

Neuroimage 2021 Feb 19:117889. Epub 2021 Feb 19.

Department of Biomedical Engineering, University of Delaware; Newark, DE, USA. Electronic address:

Novel neuroimaging techniques that can sensitivity characterize healthy brain aging and detect subtle neuropathologies have enormous potential to assist in the early detection of neurodegenerative conditions such as Alzheimer's disease. Magnetic resonance elastography (MRE) has recently emerged as a reliable, high-resolution, and especially sensitive technique that can noninvasively characterize tissue biomechanical properties (i.e. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Heterogeneity of behavioural and language deficits in FTD-MND.

Authors:
Zhe Long Muireann Irish David Foxe John R Hodges Olivier Piguet James R Burrell

J Neurol 2021 Feb 20. Epub 2021 Feb 20.

The University of Sydney, The Faculty of Medicine and Health, Sydney, NSW, Australia.

Objective: To comprehensively examine the clinical presentation of patients diagnosed with frontotemporal dementia-motor neuron disease (FTD-MND) compared to FTD subtypes. To clarify the heterogeneity of behavioural and language deficits in FTD-MND using a data-driven approach.

Methods: Patients with FTD-MND (n = 31), behavioural variant FTD (n = 119), non-fluent variant primary progressive aphasia (n = 47), semantic variant primary progressive aphasia (n = 42), and controls (n = 127) underwent comprehensive clinical, cognitive and behavioural assessments. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration.

Authors:
Fedor Levin Daniel Ferreira Catharina Lange Martin Dyrba Eric Westman Ralph Buchert Stefan J Teipel Michel J Grothe

Alzheimers Res Ther 2021 02 19;13(1):49. Epub 2021 Feb 19.

German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Rostock, Germany.

Background: Previous research has described distinct subtypes of Alzheimer's disease (AD) based on the differences in regional patterns of brain atrophy on MRI. We conducted a data-driven exploration of distinct AD neurodegeneration subtypes using FDG-PET as a sensitive molecular imaging marker of neurodegenerative processes.

Methods: Hierarchical clustering of voxel-wise FDG-PET data from 177 amyloid-positive patients with AD dementia enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI) was used to identify distinct hypometabolic subtypes of AD, which were then further characterized with respect to clinical and biomarker characteristics. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
Get 20% Off Journals at LWW.com
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap